Neri Jesse
SVP and CFO
Neri Jesse has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jul 6, 2026.
On the most recent filing, Neri Jesse is listed as SVP and CFO at ROCKWELL MEDICAL, INC. Inside the rolling window, Neri Jesse reported no open-market purchases and 1 open-market sale totaling $740 in RMTI.
Companies traded
Other insiders at RMTI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$740
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Oct 1, 2025 | RMTI | Sale | $1K |
Frequently asked questions
How many SEC Form 4 filings has Neri Jesse made?
Neri Jesse has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Neri Jesse trade?
Neri Jesse has filed SEC Form 4 disclosures for 1 company, including RMTI.
When was Neri Jesse's most recent SEC Form 4 filing?
Neri Jesse's most recent SEC Form 4 filing on Tracefour is dated Jul 6, 2026.
What is Neri Jesse's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Neri Jesse is listed as SVP and CFO.
What is Neri Jesse's total buy and sell value in the current window?
Inside the rolling retention window, Neri Jesse bought $0 and sold $740 based on SEC Form 4 filings.
What was Neri Jesse's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 886 RMTI shares on 2026-01-02, worth $740, per SEC Form 4 filings.